1,506
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Stakeholders’ perspectives on barriers to and facilitators of school-based HPV vaccination in the context of COVID-19 pandemic-related disruption: a qualitative mixed methods study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2295879 | Received 04 Jun 2023, Accepted 13 Dec 2023, Published online: 20 Dec 2023

ABSTRACT

Despite successfully implementing the Human Papilloma Virus Vaccine (HPVV) program, Saskatchewan (SK) struggled to improve HPVV uptake rates. This suboptimal uptake of HPVV with a status quo of HPV-linked cervical cancer incidence rate is mainly because HPVV’s impact on cancer prevention has not been realized adequately by vaccine providers and receivers. Further exploration of determinants of HPVV uptake is required to uncover high-resolution quality improvement targets for investment and situate contextually appropriate policies to improve its uptake. The study undertook a qualitative inquiry into understanding stakeholders’ perspectives on HPVV experience through school-based programmes. It collected data through semi-structured initial interviews (N = 16) and follow-up interviews (N = 10) from across Saskatchewan’s four Integrated Service Areas. Document analysis was conducted on all publicly available documents that included information on HPVV from January 2015 to July 2023. Thematic analysis of the data identified that inadequate information, awareness and education about HPV infection and HPVV among several groups, especially, parents, youth and school staff, was the main barrier to optimal HPVV uptake. Vaccine-related logistics, including the technical and text-heavy vaccine information sheet, understaffing, and time constraints, were other important factors that impeded HPVV uptake. A person-centred approach could educate parents in multiple dimensions.

Introduction

HPV is the commonest Sexually Transmitted Infection (STI) around the globe (Cervical cancer, Citation2023) and is responsible for more than 95% of cervical cancers (Cervical cancer, Citation2023; de Martel et al., Citation2017). HPV infection increases the risk of squamous cell cancer of various sites, including cancers of the cervix, vagina, vulva, penis, anus and head and neck region (Cancers associated with human Papillomavirus HPV, Citation2022). More than 75% of sexually active Canadians will contract at least one HPV infection in their lifetime (Canadian Cancer Society, Statistics Canada, the Public Health Agency of Canada, Citation2020). Human Papillomavirus Virus (HPV) related cancers can largely be prevented by vaccination (Canadian Cancer Society’s Advisory Committee on Cancer Statistics, Citation2016). Oncosims model projections indicate that higher uptake rates of Human Papilloma Virus Vaccination (HPVV) from 67% to 90% would result in a 23% reduction in incidence rates of cervical cancer hence causing a 23% decline in the cervical cancer mortality rate on average annually (Smith et al., Citation2019).

Canada has been a success story in launching and operating a school-based HPVV programme (Canadian Cancer Society’s Advisory Committee on Cancer Statistics, Citation2016). Despite the wide availability of HPVV through publicly funded programmes, in Canada, there are 3,800 (Citation2022) new cancer cases annually attributed to HPV (reported in 2021), and according to the estimates, this number will reach 6600 by 2024 (HPV immunization for the prevention of cervical cancer, Citation2021). Saskatchewan (SK) successfully launched HPVV school-based programme for girls (in grades 6 and 7) in 2008 (Canadian Partnership Against Cancer, Citation2021; Population health branch, Saskatchewan ministry of health, Citation2019) and expanded it to include the vaccination of boys in grades 6 in the fall of 2017 (Human papilloma virus HPV vaccine offered to boys beginning this fall, Citation2023; Population health branch, Saskatchewan ministry of health, Citation2019).

Despite successfully implementing the HPVV programme, SK struggled to improve its HPVV uptake rates. In the HPVV programme’s first year (2008–2009), the HPVV uptake rate was 74.5%, transiently increasing to 76.6% before consistently dropping to as low as 61.4% (2014/15). A report (2021) indicated that SK remains below the national target for HPVV uptake and is amongst the provinces that have “the lowest” uptake rates (Background and key statistics, Citation2021). It is likely that the underutilization of HPVV in some Canadian jurisdictions is directly contributing to the HPV related cancers burden in Canada.

We, therefore, undertook a project that first determined the current state of science on the factors that influence the uptake of HPV vaccine across English Canada (Khan et al., Citation2023) and then explored people’s perspectives on the HPVV uptake through school-based programmes across SK at three levels: patients-, providers- and system -level. We also determined the COVID-19 pandemic-related disruption of the school-based HPVV programme across SK regarding the problem, lessons learnt, and current mandate to reach HPV vaccine coverage targets. This paper reports on our exploration of the system and provider level (stakeholders) perspective on the uptake of HPVV across SK.

Methods

Study design

The project employed Qualitative Sequential Mixed Methods (Morse, Citation2010) adopting an Interpretive Description (Thorne, Citation2016) approach. Engel’s Bio-Psyco-Social lens (Borrell-Carrió et al., Citation2004) serves as the theoretical underpinning of the project, with pragmatism as the project’s philosophy. This paper reports on one aspect of our study that focuses on our exploration of stakeholders’ perspectives on barriers to and facilitators of HPVV uptake through school-based vaccine programmes from across SK. The study also determined the COVID-19 Pandemic impact on school-based HPVV programmes across SK in terms of the scope of the problem posed and the current mandate to reach the HPV vaccine coverage targets. The following research questions guided the study design:

  1. What are providers’ (supervisors and frontline workers) perspectives on provider-level barriers to and facilitators of HPV vaccination across Saskatchewan (SK)?

  2. What are system-level workers’ (immunization directors and managers) perspectives on system-level barriers to and facilitators of HPV vaccination across Saskatchewan?

  3. How has the COVID-19 Pandemic disrupted the school-based HPV immunization programme in terms of the scope of the problem posed and the current mandate across Saskatchewan to reach HPV vaccine coverage targets?

  4. What do programme documents say about the operationalization of the HPV vaccination system (i.e., programme planning, roll out, and administration of HPV vaccines) across Saskatchewan?

Using various data collection methods (interviews and document analysis), we obtained an in-depth understanding of the problem of suboptimal uptake of HPVV by exploring the system and provider-level perspective on the barriers to and facilitators of HPVV. Our review (Khan et al., Citation2023) on the barriers and facilitators of HPVV uptake across English Canada set the foundation of this research. In our review, lead author A. Khan advanced an analytical framework (see ) called “A. Khan’s Framework: Access to Care and Prevention” that adapted a patient and provider-level theme (supply-side and demand-side determinants) from Levesque’s conceptual framework of access to health care (Levesque et al., Citation2013) weaving in the system-level determinants of vaccine uptake (Beshears et al., Citation2016; Crawshaw et al., Citation2022; Fisk, Citation2021) and the determinants of vaccine uptake (Bhugra et al., Citation2021) for integration. This new combined framework (A. Khan’s Framework: Access to Care and Prevention) serves as our overall study’s theoretical and analytical framework, in which we explore both patients’ and stakeholder perspectives on HPVV uptake. The results of the patient-level analysis are reported elsewhere.

Figure 1. A. Khan’s Framework: Access to Care and Prevention.

Figure 1. A. Khan’s Framework: Access to Care and Prevention.

Study setting

SK has a land area of 577,060.4 square kilometres with a population density of roughly 2.0 people per square kilometre (Government of Canada, Canada S. Focus on Geography Series, Citation2021Census - Saskatchewan, 2022). With this large geographical space, SK has a population of 1.1 million (Saskatchewan, Citation2023) approximately half of which is sparsely distributed throughout the province outside the major cities. SK has three major cities: Saskatoon, Regina, and Prince Albert. Saskatoon (266,141) (Government of Canada, Canada, S. Profile table, Census Profile, Citation2021Census of Population - Regina, City CY [Census subdivision], Saskatchewan;Saskatoon, City CY [Census subdivision], Saskatchewan, 2022) and Regina (226,404) (Census, Citation2022) have almost similar population sizes, but Prince Albert has much less than half the population of Saskatoon (only about 38,000 people) (Government of Canada, Canada, S. Profile table, Census profile, Citation2021Census of Population - Prince Albert, City CY [Census subdivision], Saskatchewan, 2022). The two largest cities (Saskatoon and Regina) have populations of roughly 300,000 each, and the rest of the province is made up of small cities such as Prince Albert and rural towns and farming communities, plus the north which has a similar population to Prince Albert but spread over the whole northern half of the province.

The province is under the Saskatchewan Health Authority (SHA) and the Athabasca Health Authority. The southern 2/3 of the province is covered by SHA solely under provincial jurisdiction, while the northern 1/3 is covered by Athabasca health authority governed in a tripartite arrangement between the provincial government, the federal government, and the Athabasca Health Authority (Structural Profile of Public Health in Canada: Indigenous health National Collaborating Centre for Healthy Public Policy, Citation2019). School locations are more widely spaced out as the population becomes sparser, making school-based immunization programmes more logistically challenging.

Although this study was conducted in Saskatoon, the largest city in the province of SK by population and area (Wikipedia contributors, Citation2023) the interviews with stakeholders (providers and system-level workers) were conducted from across SK throughout four integrated service areas. In SK, the HPV vaccine is offered through publicly-funded school-based vaccination programmes through coordination between local public health units and school staff to all students in grade six (HPV vaccine access in Canada, Citation2022, Citation2022). Besides the school-based programme, the HPV vaccine can be administered at public health clinics to catch up for missed opportunities. Public health nurses collect informed consent letters and administer the vaccines.

Participants recruitment

We employed a purposive sampling strategy for participant recruitment from across SK throughout SHA. We aimed for diversity in the sample based on the roles and positions of the participants and the area/region they work in for initial interviews and follow-up interviews to obtain a representative sample. We aimed for diversity in the sample to procure rich insights and capture multiple and different perspectives that fulfil the study aims by allowing exploration of barriers to and facilitators of HPVV uptake.

In the context of this study, we classified stakeholders into provider and system-level workers. The provider-level participants include frontline workers and supervisors who work at the provider level in the HPV immunization programme, planning, roll-out/delivery, and administration and represent the population and public health staff from primary health care networks. The system-level participants include directors and managers who work at the system level in the HPV immunization programme, planning, roll-out/delivery, and administration and also represent the population and public health staff from primary health care networks.

In collaboration with XXX and YYY, the study recruitment e-poster was circulated among the population and public health staff from primary health care networks for recruitment for initial interviews. XXX and YYY facilitated the identification of participants geared by a network of people working in vaccination-related roles across all four Integrated Service Areas (ISA) (Saskatoon, Regina, North and Rural) under the XXX. A population health research specialist who is a trained physician recruited the participants by working closely with a Senior Medical Health Officer and Epidemiologist with a vast experience with vaccination-related research. Using the same network, we again reached the same target population for the follow-up interviews.

We reached the potential participants through email with participant recruitment material consisting of an invitation letter, an information sheet briefly describing the study, and a consent form. We scheduled interviews with the participants who expressed interest in contributing to the study. On the recruitment poster and the information material shared, we clarified that the participants would not be compensated for participating in the interviews for this study and that consenting to be interviewed means contributing to a better understanding of the problem in question. Therefore, no participants were provided compensation. Moreover, we conducted the interviews during work hours, and these were deemed relevant to the participants’ work.

Data collection

We conducted individual semi-structured interviews between October and December 2022 and follow-ups between March and April 2023. Based on participants’ preferences, all interviews were conducted over virtual platforms (either zoom or Webex) in Saskatoon at the XXX at XXX. The office is well-equipped for audio and video conferences and suitable for conducting interviews. In total, we conducted forty-one (N = 41) interviews with (n = 31) initially and (n = 10) follow-up interviews. Based on the stakeholder classification we made, the participant distribution was as follows: In initial interviews, provider-level participants were (n = 15), whereas the system-level participants were (n = 16). In the follow-up interviews, provider-level participants were (n = 6), and system-level participants were (n = 4). All the interviews were audio recorded. Initial interviews lasted 1 to 1.5 hours, whereas the follow-up interviews lasted a maximum of one hour.

We used an interview guide (see supplementary material, interview guide 1 and 2) informed by our review and guided by A. Khan’s Framework: Access to Care and Prevention (Khan et al., Citation2023) for developing interview questions drawing on the most prominent themes related to the HPVV uptake factors in the broader context (English Canada) that emerged from the review (Khan et al., Citation2023) and identified in the A. Khan’s Framework: Access to Care and Prevention (see ). During the initial interviews, we collected brief demographic information from the participant to learn about the participants’ characteristics. We asked participants about their perception of the operationalization of the HPV school-based immunization in SK before the COVID-19 pandemic—also the COVID-19-related disruption of the school-based HPVV programmes.

The follow-up interview guide (see supplementary material, interview guide 3) was developed from key themes emerging in the analysis of the first set of interviews. We combined stakeholder groups (system and provider level) and interviewed a subset of the same participants interviewed in the initial interviews. Conducting interviews this way allowed us to expand on the areas of significance that were still ambiguous and find agreements, disagreements, resonances, dissonances, and nuances as a part of data crystallization. We commenced data analysis immediately following the first interview and continued until we obtained thematic saturation (Green & Thorogood, Citation2018; Saunders et al., Citation2018).

We also conducted a document analysis and reviewed all publicly available provincial documents from January 2015, until July 2023, that included information on HPV immunization. Data were retrieved from the official database of Saskatchewan’s resident health access and immunization services website (Immunization services, Citation2023) using the keywords HPV immunization, HPV vaccination and HPV vaccine. In addition, we obtained some documents from the immunization leads, specialists and coordinators. We reviewed the following data sources: Saskatchewan Immunization Manual, Vaccine-Preventable Disease Monitoring Report, Guidelines for Administering HPV-9 PPHS—Specialty Immunization and Travel Health Centre, Grade 6 Immunization Package and Provincial School Immunization Policy.

Data analysis

All data were audio-recorded and transcribed verbatim. Data analysis was facilitated using the qualitative software NVIVO 12. We analysed the two sets of interview data using a thematic analysis approach by adopting hybrid inductive-deductive coding and following the six pragmatic steps described by Braun and Clarke (Braun & Clarke, Citation2006). The six steps included data familiarization, generating initial codes, searching for themes, reviewing the themes, defining, and naming the themes and producing the report (Rezaei Aghdam et al., Citation2020). Data for document analysis was extracted by carefully reading the selected documents several times. We analysed the abstracted data from the document review with the interview data using a thematic approach to identify possible barriers to HPVV uptake and potential areas of improvement to enhance HPVV uptake. We organized the data extracted from the selected documents on three axes (target, action and means) of the WHO International Classification of Health Interventions (ICHI) tool (World Health Organization, Citation2001). We carried out deductive data coding based on the lead author’s HPVV uptake framework (A. Khan’s framework) and inductive coding for emerging themes. Six key themes were identified, ranging from the ubiquitous provision of HPVV and acceptability to vaccine attitudes.

We aimed for crystallization, a type of data triangulation, to compare different data sources to enhance the trustworthiness of the study findings by allowing the exploration of diverse perspectives and an opportunity to corroborate and elaborate some of the claims made by the study participants. We aimed not only to find convergences of findings at some specific “truth” but also seek dissonances among different data sources and participants to facilitate our understanding of why (Tracy, Citation2010) there is a suboptimal uptake of HPVV despite the wide availability of this vaccine through the publicly funded programme. Also, to enhance the trustworthiness of the study findings, we conducted a member-checking exercise by discussing study findings during the follow-up interviews with the participants we interviewed initially. Doing so allowed the participants to comment on the emerging themes, reflect on the study findings and provide suggestions. We also ensured including the voices of multiple participants to capture diversity in perspectives and enhance study rigour.

Ethical considerations

We sought approval for the study and evaluation protocol (including recruitment strategies and data collection tools) from the University of Saskatchewan’s Behavioural Research Ethics Board (Application ID#: 3545). We also obtained a letter of authorization to conduct research from the Saskatchewan Health Authority. We collected informed consent from all the participants before the interview. Before data analysis, we removed all identifying data in the verbatim transcripts.

Results

Participant characteristics from initial and follow-up interviews

We conducted a total of 41 stakeholder interviews. Overall, there was a nearly even split between the type of stakeholders interviewed in phase 1, with 49% provider-level participants and 51% system-level participants. In phase 2, however, the divide was 60% (provider-level participants) and 40% (system-level participants). We interviewed two types of health professionals in both phases: Medical Health Officers (MHOs) and Public Health Nurses (PHNs). The PHNs interviewees reported assuming different working roles and positions that included: immunization coordinators and specialists, PHNs clinical supervisors and consultants, front-line PHNs, directors, executive directors and managers of primary healthcare, and supervisors, managers, and directors from Clinical Integration, Clinical Standard and Professional Practice.

Saskatchewan Health Authority operates through health networks across Saskatchewan through four main areas called Integrated Service Areas (ISA). The four ISA includes Saskatoon, Regina, North, and Rural. In both phases, our participants’ representation was highest in the Rural (N = 17) and lowest in Saskatoon (N = 3). Participant representation from Regina was in the mid, i.e. (N = 6) in the initial, which decreased in follow-up interviews (N = 2). In contrast, this was higher in the North in initial interviews (N = 11) than in the follow-up interviews (N = 2). Please refer to for detailed demographic characteristics of stakeholders participants from initial and follow-up interviews.

Table I. Demographic characteristics of stakeholders participants from Initial and follow-up interviews.

Provider and system level barriers to and facilitators of HPVV uptake

We report barriers to and facilitators of HPVV uptake from interviews and document analysis based on the key themes. The key themes are 1. Information, Awareness and Education. 2. HPV Vaccine-Related Logistics. In discussing the results, we further divide these themes and subthemes related to barriers to or facilitators of HPVV uptake. We found similar key themes in initial and follow-up interviews with system and provider-level participants; however, they vary slightly based on the point of emphasis; for example, provider-level stakeholders thought that the vaccine information sheet was too technical to read and understand, whereas system level stakeholders believed that it is the mode of distribution of the vaccine information sheet (via only paper copies) that serves as the biggest roadblock in ensuring the information reached to parents.

Information, awareness and education: barriers

This first key theme and the corresponding sub-themes fall under the following determinants of vaccine uptake included in the A. Khan’s Framework: Access to Care and Prevention (Khan et al., Citation2023) (see ): vaccine attitudes, approachability and ubiquitous provision. These are the system and provider-level determinants driven by the psycho-social elements in the A. Khan Framework. provides a detailed overview of stakeholder perception of barriers to and facilitators of HPVV under theme#1 (information, awareness, and education): sub-themes, factor type (barrier vs facilitator), and exemplar quotes.

Table II. Stakeholders’ perception of barriers to and facilitators of HPVV under Theme#1 (information, awareness and Education): sub-themes, factor type (Barrier VS Facilitator), and exemplar quote.

Provider-level stakeholders communicated that one of the many barriers is inadequate awareness or low literacy on HPV infection and HPVV. They emphasized educating three key population subgroups: youth, parents, and school staff. They also highlighted a need for clear messaging in the school and for providing additional educational avenues for children and youth because they are the ones who get needles in their arms. Provider-level stakeholders articulated that children and youth education about HPV infection and HPVV is critical. They believed investing in students’ education would help establish trust in the vaccine and providers.

Similarly, system-level stakeholders reported insufficient avenues for information exchange with parents. They highlighted that parental awareness of existing avenues is important to enabling them to navigate the information package sent to them through the school-based immunization programme. They highlighted a need for parental education in multiple dimensions, including providing the right information, dismantling myths, and misconceptions, and addressing specific questions and concerns by adopting a person-centred approach. They exemplified that parents recognize HPV as a sex-related vaccine.

One is parents’ preconception that HPV is a sex vaccine; it might give young ones the freedom to involve themselves in risky behaviours.” … … …. (System level Participant, Initial Interview#6)

Provider-level stakeholders advocated for periodic training and refresher courses on HPV infection and immunization for health care staff, including immunization staff and public health nurses. They urged that engaging school staff through educational workshops would help them cope with the students who do not bring the consent form back to school and may motivate them to bring back consent. They also stressed targeted education to vulnerable communities and discouraged reluctance and hesitancy in reaching out and educating these population subgroups due to the fear of singling them out.

So, I think targeted education is the key. We have to take a closer look to see if there are sub-populations; if we can identify that, then targeted education to those populations would be helpful, but I understand we struggle with that because nobody wants to single anyone out and go out specific populations. The education piece is important that targets sub-populations who have maybe caught onto the misinformation that’s circulating, and this should be done with a consistent approach all across. … … … … .(Provider level Participant, Initial Interview#11)

In addition to highlighting the population subgroups that should be targeted for educating about HPV infection and HPVV, HPVV-related misconceptions must be addressed. In that, they cited that parents consider HPVV a controversial vaccine. They also reported observing a misconception among parents about using the HPVV and the potential of promiscuity in youth, which served as an important barrier to HPVV uptake. Due to similar reasons, many parents were not convinced that the HPVV should be given to children, as they do not believe their child(ren) is at risk. Moreover, parents were reluctant about the HPVV due to their concern and uncertainty about HPVV safety.

System-level stakeholders emphasized that the most prevailing misconceptions about HPVV among parents were driven by their fear that getting HPVV would make their children promiscuous. These misconceptions support parents’ belief that their child(ren) will not be involved in sexual activity and will completely abstain from it until marriage; therefore, they do not require the HPVV. Additionally, system-level participants cited that parents face several barriers to seeking HPVV: being too young to get the vaccine, the belief that their children are not sexually active, the risk of encouraging them to involve in sexual activity or related risky behaviours, and that HPVV is for females only as it can protect them from having cervical cancers.

System-level stakeholders also expressed concerns that parents were uncomfortable conversing with their children about the HPVV and the why of its importance because, as some parents find the administration of the HPVV morally objectionable, others are not yet ready to believe that their children will be reaching the age where they will be sexually active, and this makes it more difficult for parents to navigate the situation then and decide to consent or decline the HPVV.

System-level stakeholders identified inadequate physicians’ leadership outside public health to help enhance HPVV uptake. They highlighted that people seek healthcare in many ways and that there are insufficient avenues that could remind people about HPV infection and highlight the role of HPVV in preventing HPV-linked cancers. They believed that periodic education with a repeated offer of HPVV at different healthcare encounters would collectively work to serve the purpose.

But it’s another space where we don’t have the best at all, is that, okay, if we decide that we can’t build capacity like we want, amongst pharmacists, amongst NPs, amongst primary care physicians, amongst massage therapists—any other care providers, people seek healthcare in a lot of ways—there is very little to no mechanism for them to refer in a way that matters for the client, to a public health nurse. To help facilitate a conversation. If they want to refer to public health, it’s not tidy. It’s actually really messy. We don’t have a place to send. We don’t have a vaccine-hesitant clinic.… … … .(System level Participant, Initial Interview#8)

Information, awareness and education: facilitators

System-level stakeholders identified important groups that need education about HPV infection and the role of the HPVV. They strongly suggested educating parents, families, children, and youth by incorporating health literacy in the school curriculum, expanding the concept of immunization and providing vaccine education adopting a health-promoting school model. Educating the vaccine receivers (children) would be valuable as the vaccine end-users will converse with their parents and families serving as vaccine consenters. Moreover, this idea reinforces valuable informed consent.

The idea of using health promoting schools model, which we do struggle a lot to get in Saskatchewan, would be a big facilitator, because, by default, everyone who attends school on a regular basis at that level is certainly a space for them to understand and start exploring, and be able to know how they can take steps if they want to know more and do want to seek immunization.…….(System level Participant, Followup Interview#9)

Additionally, provider-level stakeholders emphasized targeting the challenges of communication youth use these days to put a message about HPV infection and the role of HPVV. Besides, PHNs and other immunization staff should be offered periodic education through workshops, refresher courses or training in a persistent fashion. Doing so would equip the staff with the knowledge and confidence required to handle the stigma attached to HPVV and address parental concerns better. This may range from engaging the parents in conversations and managing the components of vaccine hesitancy in them at large.

Provider-level stakeholders identified school staff amongst the important groups instrumental in navigating immunization administration between PHNs and parents of the child(ren) behind in immunization without confidentiality breach. Therefore, it is crucial to first engage with school staff, highlight the importance of HPVV, and collectively work on a plan to connect with parents so that PHNs can address parents’ concerns in case-by-case consultations to avoid the stigma attached to the HPV vaccine.

Provider-level stakeholders cautioned that teachers should carefully set this connection up to avoid confidentiality threats and any change to enhance stigma for those behind in immunization. One-on-one interaction opportunities between PHNs and parents and group interaction with school staff were considered important avenues that could facilitate HPVV uptake. In addition, educational campaigns, the use of social media, and infographic posters in school were additional pieces stakeholders believed would help improve vaccine confidence and increase HPVV uptake.

I think we need to do better education, of course, whether it’s social media or going to the schools, and I feel the face of the public health nurse needs to be there more. I know we’re busy, but trusting your public health nurse is so big, it really is. It makes me sad when I go to my school, and my kids go to my school, and the kids go, ‘Ahhh,’ because they know needles are coming. I used to go and talk to kids or pick up or whatever; you’re just there; you don’t want to be that scary face.…….(Provider level Participant, Initial Interview#13)

Other groups that the system level-stakeholders identified require education included Community Health Workers (CHW) and religious leaders and stakeholders. Stakeholders highlighted that educating the CHW would serve as impactful facilitators through their unique role in community outreach, especially in reaching population subgroups and addressing their concerns. CHW’s training should also involve learning ways to deal with different subgroups in the community. Stakeholders highlighted that it would be ideal to have CHWs with diverse backgrounds who can connect well with diverse communities across SK.

System-level stakeholders highlighted the importance of educating religious leaders and stakeholders as a good section of society follows them and relies on them in decision-making. Therefore, providing religious leaders and stakeholders with health information in a broader context and sensitizing them about the HPVV would be an excellent way to create awareness. In this way, an avenue can be identified and set up to address people’s concerns about taking certain kinds of medicine because they think taking a vaccine is prohibited by religion in some sense.

Some system-level stakeholders also advocated for physician leadership outside of public health to promote HPV immunization by educating people directly, engaging with them at the first opportunity, and trying to use different points of healthcare-related access to remind them of HPVV and the consequences of long-term HPV infection.

In every population, every person trusts a different person, a different healthcare worker. If a public health nurse says it, sometimes they just won’t listen, but if they go to their doctor and the doctor says it, they’ll listen. Not necessarily the giving of the vaccines, just the education piece. I really think that’s important, especially with vaccines like HPV. I’ve said numerous times trust is big. We really need to work together; we need to be one big team. We all have to be on the same page and understand the science behind vaccines, and that they’re important, this is why it’s safe and why we should do it. There are so many different access points.………….(System level Participant, Initial Interview#2)

HPV vaccine-related logistics: barriers

This second key theme and the corresponding sub-themes fall under the following determinants of vaccine uptake included in the A. Khan’s Framework: Access to Care and Prevention (Khan et al., Citation2023) (see ): availability and accommodation, approachability, appropriateness, acceptability, and cost. These are the system and provider-level determinants driven by the environmental elements. provides a detailed overview of stakeholders’ perceptions of barriers to and facilitators of HPVV under theme#2 (vaccine-related logistics): sub-themes, factor type (barrier vs facilitator), and exemplar quotes.

Table III. Stakeholders’ perception of barriers to and facilitators of HPVV under Theme#2 (vaccine-related logistics): sub-themes, factor type (Barrier VS Facilitator), and exemplar quote.

Provider-level stakeholders cited several concerns about the immunization packages sent home via school-based vaccine programmes. These packages contain a vaccine info sheet as well as a consent form. They highlighted that the vaccine information sheet needs to be more concise and less technical. Stakeholders suggested that the vaccine information sheet could be less text-heavy, avoid using many medical terms and serve as a more user-friendly guide, so the lay public can easily read and understand.

Provider-level stakeholders discussed that many people in SK assume English as a second language; therefore, they do not read the information sheet or do not understand it entirely if they choose to read it. As a result, many do not provide consent for HPVV. Stakeholders stressed the importance of understanding the immunization material to guide decision-making for filling out the consent form. Otherwise, the consent obtained might not be “informed consent,” and—is something Stakeholders were not comfortable with hence flagged it as an area that requires further exploration.

I just compare that to my family. My husband’s a farmer. If I handed him my children’s vaccine information sheet, he’d take one glance at it and see how much reading he has to do. He’s a Grade 12 graduate. He’s not a college graduate. He does well with his work but can’t be bothered to read. It’s like, just give me the highlights here. The general public just wants the highlights, so sometimes they’re signing these consents and probably not reading the information sheet. One of the things we already talked about was the consent form and the information being too busy and too difficult to read and complete. .(Provider level Participant, Initial Interview#11)

System-level stakeholders highlighted that the vaccine information sheet is not of substantial standard, and it is designed to be very politically correct or legally precise, where one is given a lot of information with little to no concern if the message it aimed to deliver did get across. Stakeholders believed the vaccine information sheet was the main barrier to HPVV uptake for many reasons, i.e., not up-to-date, had a high reading level, technical, text-heavy and not a user-friendly guide.

Yeah, I think I’ve said the same thing that our sheets are garbage. I actually really like the idea of the language of politically correct, because my mentality about the fact sheets has been due to who produces them and who owns them; there is a significant sense of protection against liability, not about- That’s the priority. Think about the planning [inaudible, 00:29:53]. These sheets, it’s akin to that big, long document inside the pill box, that because they made that, if you have one of those adverse events and you didn’t read it, well, it’s on you now. Right? And that’s the way the fact sheets are right now. They scream I have to put everything, and I have to be very correct about it; I have to be legal. Not politically correct, I would say legally precise, to protect against liability. Which, we certainly know, does not align well; hilariously, what a logical person would dictate is what is necessary to make an informed decision. .(System level Participant, Followup Interview#7)

Stakeholders cited understaffing, time constraints, difficult catchup for missed opportunities, work overload, burnout, lack of appreciation, and early retirements as the most significant and interrelated factors that impede HPVV uptake. They expressed frustration with staffing constraints which leads to difficult catchup for missed opportunities for a variety of child(ren), i.e., truant, sick on needle day, frequent movers, homeschoolers, online learners, and new admission. They also discussed that multiple attempts to reach parents to seek consent for HPVV and difficult catchup with those children who are behind in immunization is time taking and pose challenges to already constrained time. These factors lead to work overload and burnout, which is especially challenging after the COVID-19 pandemic.

System-level stakeholders viewed understaffing as a political barrier as they voiced concerns about not hiring staff in the face of persistent short staffing. They also suspected that such an attitude might be grounded in personal or political benefits geared by the plan to devolve public health. They cited that a lack of recognition of the PHNs’ work and struggle with navigating through the “thick and thin” that comes their way in getting the needle into people’s arms is one of the main factors many staff decide to retire early.

They also recognized that early retirements of the immunization workforce add to the already exhausted staff, time, and their energies hence serving as significant barriers to HPVV uptake. System-level stakeholders counted all these factors as barriers to effective HPVV uptake by end users. They felt that healthcare personnel should be treated well by all despite an existing hierarchy in the system, as a failure to do so poses challenges to the sustainability of the healthcare system hence increasing the immunization workforce.

Provider-level stakeholders also reported some stand-alone barriers in addition to the interrelated barriers discussed above. They reported school spacing for needle administration and confidentiality issues to impact HPVV uptake. They complained that the space allocated by the school to set up a vaccine clinic has less room with no proper furniture. PHNs find it extremely challenging to set up a vaccine clinic in a congested space and be able to administer vaccines comfortably. They were frustrated that schools sometimes do not contribute adequately to help maintain the confidentiality of students receiving needles, especially when PHNs are given gym areas to queue up children and administer the needle to grade sixers. HPVV comes with a stigma, and confidentiality issues could significantly impede HPVV uptake.

Provider-level stakeholders also identified the suboptimal needle spacing for grade sixers as they are offered multiple vaccines in the same grade. They articulated that the grade sixers voiced being traumatized by having many needles at a time due to a suboptimal time between different needle administrations. They highlighted that suboptimal needle spacing was a constant barrier as there had been an effort to change a policy and possibly provide needle spacing between a few vaccines given in series, but the efforts remained unsuccessful. Finally, system-level participants cited HPVV cost as an important issue because they believe getting HPVV is difficult for those individuals who must pay for it once they cross the eligibility age.

HPV vaccine-related logistics: facilitators

Provider-level stakeholders suggested changing the distribution mode of immunization material from a paper copy mono-strategy to a hybrid strategy. A hybrid strategy could involve a paper copy with an electronic reminder because solely relying on a child to take the consent form home and bring it back to school has not been the best way to distribute immunization packages as it comes with many challenges, e.g., loss of consent form, etc. Therefore, adopting a hybrid approach would likely enhance the return rate of the consent form because it will cover both types of parent groups those who are more technology smart and those who find paper forms easy to fill and return. They also advocated translating immunization material (vaccine info sheet and consent form) into different languages and making them available through school-based immunization programmes.

Well, my thoughts, probably if you could do a blended method. So, you could do paper or electronic, whatever a parent wanted. Because some parents are really techy, and they know things are coming into their inbox, they’ll be checking and seeing it. ‘Great, yeah, let’s do that,’ get it back, dat-dat-dat, get it back, good. Versus other parents don’t have the capability to be techy, so then they need that paper to come home, and they need to sign it, and they need to get it back. But of course, that means the child has to get it home, and the child has to get it back. But I mean, if it works for that family, great. So, probably a blended method, depending on what the parent, what works best for the parent, that’s probably what I would suggest. (Provider level Participant, Initial Interview#2).

Provider-level stakeholders suggested following the COVID-19 vaccine model to amend the vaccine information sheet and creating a user-friendly guide that contains information on the possible questions, people would like answers to and includes all relevant information. They emphasized the proper promotion of HPVV with a cancer prevention focus instead of a sexual infection focus because a disproportionate emphasis may mislead parents who are already ambiguous about the need for HPVV for young folks who are not yet sexually active. Therefore, reorienting the emphasis by highlighting that this vaccine prevents cancers of cervical, anogenital and oropharyngeal cancers as opposed to starting the information sheet with a focus on sexually transmitted infections. Provider-level stakeholders clarified that reorienting the focus does not mean removing information about STIs but rather rewording appropriately down the information sheet.

I think number one, it’s on the information sheet, one of the first couple lines, ‘it protects against sexually transmitted diseases,’ I think that just stops parents. Because, in their mind, my grade six isn’t sexually active……(Provider level Participant, Initial Interview#5)

System-level stakeholders suggested developing a data platform to link the school data system and immunization database where there is a direct flow of information exchange between the two while maintaining confidentiality. In this way, many children who are behind in immunizations can be reached. In addition, stakeholders considered that changing the HPVV from a dosed series to a single shot would enhance HPVV uptake rates. They also suggested removing the age cap for getting HPVV for free or expanding the eligibility age from 27 to 47. Doing so will include a broader range of population subgroups and enhance HPVV uptake rates. Finally, stakeholders strongly believed that a team approach for HPVV delivery and administration is required to settle the spacing issue in schools.

Document analysis revealed a few key themes and subthemes that fall under the following domains on A. Khan’s Framework for Access to Care and Prevention: vaccine attitudes, ubiquitous provision, catchup programmes, approachability, availability, acceptability, appropriateness, and accommodation driven by the psycho-social, environmental/contextual circumstances. In terms of facilitators that existed already: documents reflected a broad focus on all population types, including special populations such as those having specific diseases/conditions as well as those whose immunization record is not certain (internationally adopted children from orphanages, refugee children and immigrants’ children) regardless of their place of birth and aimed to get the needle in their arm at the first opportunity. If such practice continues, it will serve as a strong facilitator that keeps HPVV uptake rates high.

Among the barriers noted, several important ones included: First, there was no agreed-upon provincial surveillance case definition for HPV cases, as HPV cases are not reportable in SK. This serious barrier hinders HPVV uptake rates as we do not have statistics to know how many cases we have in SK with HPV-related diseases. Second, guidelines around HPVV effectiveness, safety, and recommended intervals have been given briefly, with appropriate links to the relevant sites for detailed information.

Also, the highlights in the vaccine guideline did not include all the information needed to use HPVV safely and effectively when a client takes the vaccine off-label leaving a space for ambiguity. In that, the highlights could be elaborative and direct. Third, the documents serve as a classic example to illustrate a layperson’s struggle to complete the consent form and clearly understand the role of HPVV due to insufficient information on HPV infection and HPVV. The information provided in the document was not easy to understand, especially for subgroups assuming English as a second language.

The COVID-19 pandemic impact

We report the COVID-19 pandemic impact based on (1) the problem posed due to the COVID-19 pandemic-related disruptions of school-based immunization, (2) the current mandate to reach the coverage target and (3) lessons learnt. We found two broad factors of prime significance under the impact of the COVID-19 pandemic (a) resource sacristy and (b) vaccine scepticism and reported them based on the type of impact it has posed, i.e., negative or positive. Negative impact reflects factors that impede the uptake of HPVV, whereas positive impact reflects factors that likely enhance the HPVV uptake. Please refer to for a summary of the COVID-19 Pandemic impact with themes, subthemes and exemplar quotes.

Table IV. COVID-19 pandemic impact on school-based HPV immunization programme: categories, themes and exemplar quote.

The COVID-19 pandemic impact on school-based HPV immunization programme: negative impact

(1) Resources Scarcity

All the stakeholders expressed concerns and frustration with the lack of resources. Understaffing, time constraints, backlog, workload, staff reallocation and work redistribution were considered factors originating directly due to the lack of human resources. These factors led to inconsistent local response across regions of SK during the COVID-19 pandemic based on the local ability, which led to difficult catchup on immunization, and challenges of vaccine handling and storage. Providers voiced concerns about all efforts to address the COVID-19-related work and vaccine rollout with little to no plan to carry out at least some of the routine public health activities and services. Deprioritizing other public health services resulted in outbreaks of infectious diseases, such as HIV and syphilis, which are already at higher rates across SK, and complete neglect of Health Promotion.

STIs were not tested, and we did not have time to follow up the cases and the contacts, so we have now too many cases of syphilis and other STIs that were not tested, and they spread. So, that’s another side of looking at it, if something happens in the future, how the public health staff will be able to carry on their local, routine services, Communicable Disease Control, Immunization, the Public Health Inspectors carrying on their public health visits, inspections and everything. So much got lost, not only immunization; our immunization rates have dropped, syphilis is out of control, HIV. We’ve had significant increases in cases of HIV; it’s appalling, actually.… . (System-level Participant, Initial Interview#3)

(2) Vaccine scepticism

Stakeholders expressed concerns that they observe more vaccine hesitancy among parents and that children are more anxious about immunization at school or when brought to public health clinics or mass immunization centres. This increased vaccine hesitancy has resulted in more interrogation for other routine vaccines, lower return of consent forms, more refusal of vaccines, and more parents wanting to be present with their child (ren) at the time of immunization. Therefore, more of these parents chose to book an appointment with public health clinics to bring in their child instead of seeking the same vaccine through the school-based immunization programme. Public health clinics are over capacity because they are set up mainly for preschool immunization and other programmes. It is difficult to accommodate the population from school after missing the opportunity. Stakeholders also discussed challenges navigating through school staff to deliver school-based HPV immunization programmes as the COVID-19 pandemic-related disruption of the school-based vaccine programmes disrupted the long-standing relationships between school staff and PHNs. As a result, there is the hesitant resumption of former needle programmes in schools, posing barriers to already overworked staff dealing with huge backlogs and playing catchup. Stakeholders believed that public mistrust of public health and the health system vaccine had catalysed vaccine scepticism due to multiple restrictions proposed by public health.

Again, the next big one was the trust/mistrust with the public health system, or the health system in general. Lessons for me though, too, not with regards to students at all is that, us as a program are very flexible. When we talked to people trying to get consents like you get the idea that they feel like the government is trying to control them. We’ve heard a few things that now they’re thinking that HPV vaccine is a new vaccine, so they don’t trust it. It’s something they were familiar with before, like the old diphtheria and tetanus and stuff that families are used to. So, there’s more distrust in the HPV vaccine.… … … . (Provider level Participant, Initial Interview#5)

The COVID-19 pandemic impact on school-based HPV immunization programme: positive impact

The COVID-19 Pandemic: An Example

All Stakeholders considered adopting strategies adopted during the COVID-19 pandemic for mass immunization and infection containment. Stakeholders suggested the same strategies for vaccination against HPV through public messaging and provincial and educational campaigns. The efforts invested in addressing the COVID-19 pandemic through technology have led us to upgrade and modernize public health. The COVID-19 pandemic proved that public health could be flexible in adopting a hybrid way of collecting consent for vaccines from parents by switching from school-based immunization to in-clinic. This adaptation provides the idea that a hybrid approach could result in sorting consent and being able to immunize. Moreover, during the pandemic, the rigorous use and practice of the Infection Control Guidelines became second nature in clinics, resulting in a positive behavioural change. Finally, many stakeholders considered that the COVID-Vaccine-related success turned many vaccine-hesitant into vaccine inclined. Therefore, they deemed that the COVID-19 pandemic can be an example to guide day-to-day public health practice in many dimensions.

Current mandate across Saskatchewan to reach HPV vaccine coverage targets

Alternative Vaccine Clinics

Stakeholders across SK reported different and related plans to catch up with immunization based on their local ability. The plans for immunization catchup included mass clinics, community clinics, drive-through immunizations, and additional and extended-hours clinics to reach the HPV vaccine and other vaccine coverage targets that were neglected during the COVID-19 pandemic. Additionally, stakeholders also mentioned plans for more trips to school and mass clinics, with some schools catching up with immunization that is more classroom-focused as opposed to grade-focused. Stakeholders from some regions also plan to immunize in “Blitz” and then transition to “Strategic” because they believe what works for one area does not necessarily work for others, as the number needed to be immunized larger than the provider pool.

Hybrid Types of Immunization Clinics, such as drop-in, school-based, centre-based, physician-based, and pharmacy-based immunizations, are also being considered to reach a mass population. Inside-school and outside-school vaccination connect are planned to get the target audience on immunization using different access points. Interestingly, a stakeholder reported “no plans” to play catch up in their area as they could keep up with vaccination because the region had an ability, based on their locality, to decide on their own. They did not suspend school-based immunizations. The stakeholder called this an anomaly as the COVID-19 pandemic did not impact that area from keeping up with immunization. Please refer to for a summary of the current mandate to reach HPVV coverage targets: themes, subthemes and exemplar quotes.

I know that we’re a little bit of an anomaly, as certainly in rural health because we did make the decision that we were not going to suspend these school-based immunizations during the pandemic. We actually didn’t have any of them that were missed, so we don’t feel that we have to catch up. Part of our rational for that was, we said, ‘We don’t want to come out of this pandemic only to have children —’ I mean, HPV isn’t going to be a pandemic or an epidemic, but we didn’t want to come out of the pandemic with an epidemic of measles or an epidemic of mumps or an epidemic of whatever because we didn’t keep up with these. So, we just felt that that was an important priority. As far as the COVID-19 having an impact on us keeping up with those immunizations, that is not the case here.………(Provider level Participant #10)

Table V. Current mandate across Saskatchewan to reach HPV vaccine coverage targets: categories, themes and exemplar quote.

Lessons learnt due to the COVID-19 pandemic

Gaps in Public Health Systems Planning and Operationalization

Stakeholders deemed that although they could draw from many lessons, they learnt from the COVID-19 pandemic-related change in public health operations. One critical lesson learnt from the pandemic was that everyone at all levels of the public health and health system realized that serious gaps existed in the public health and health system planning and operationalization. During the COVID-19 pandemic, resources in all capacities were stretched thin. We realized how fragile our public health system is that it lacks a contingency plan in its day-to-day operations and does not have a solid plan to follow and policy to enact to respond to emergencies. The stakeholders expressed frustration that even the H1N1 pandemic was a big lesson that could lead us to formulate a robust emergency preparedness plan, but that was not the case.

Stakeholders articulated that many immunization-related and interrelated issues arose during the COVID-19 pandemic due to a lack of a robust plan to deal with emergencies. These issues ranged from not having a working policy for the mature minors’ consent to immunization hype to deprioritizing everything but COVID. They discussed how they felt and struggled when they had to work to get the immunization done at the first opportunity. As to them, failure to do so might mean they might never get it again, or at least it would be difficult to do that then. Please refer to for a summary of lessons learnt due to the COVID-19 pandemic: themes, subthemes and exemplar quotes.

Table VI. Lessons learnt during the COVID-19 pandemic: themes, sub-themes, and exemplar quote.

Stakeholders were frustrated and stated that the COVID-19 pandemic had renewed an emphasis on lacking public health personnel planning. The stakeholders were demoralized by the public loss of trust in public health and the health system due to the proposed restrictions and temporary misfit policies. They cited long-term consequences of short-term policies that misfit with the local abilities across SK as local abilities vary widely in terms of the location of the region (e.g north, rural VS Saskatoon and Regina) and the population they serve. Stakeholders suggested tailored strategies to cope with inconsistent local abilities instead of a provincially dictated one size fits all strategy. Stakeholders emphasized the need for long-term sustainable plans to promote and sustain health promotion—an already uphill battle! Stakeholders highlighted a clear need for practicing a long-suggested “Patient-Centered Approach” to provide routine services and a plan on similar lines for emergency services.

Though another lesson learned is that how fragile our current public health system is. And its resources. That it was unfortunate throughout that period that we had to prioritize COVID and COVID vaccine over school-based immunization because it was really ethically difficult. For both the public health staff and the administration staff to have to make those choices and prioritize one thing over another that are equally important.….(System level Participant, Initial Interview#4).

Discussion

The study overall sought to gain an in-depth understanding of perspectives on the uptake of HPVV at three levels (patients, providers, and system). This paper reported the following aspect of the study: stakeholders’ perspective on HPVV uptake and also presented findings about the COVID-19 pandemic-related disruptions of the school-based HPVV programme regarding the scope of problems posed and the current mandate to reach HPVV coverage targets.

The study’s main findings are (1) stakeholders perceive that (a) information, awareness and education and (b) vaccine-related logistics are significant in the uptake of HPVV. (2) Stakeholders reported scarcity of resources and vaccine scepticism as the most significant problems posed by the COVID-19-related disruption. In contrast, stakeholders suggested that the COVID-19 pandemic can be an example to guide day-to-day public health practice in many dimensions. (3) Stakeholders planned alternate vaccine clinics and routes to catch up with immunization to reach target coverage rates. They reported that the biggest lesson learned from the COVID-19 pandemic was the serious gaps in public health systems planning and operationalization related to routine services and emergency management.

The study findings agree with the literature that determinants of HPVV immunization uptake are broader in context and difficult to encompass comprehensively. The determinants vary on the bio-psycho-social- environmental- and -political axis. Our study corroborated the factors on HPVV uptake we had previously summarized in our review from across English Canada (Khan et al., Citation2023) in the context of SK. The study findings align with the literature that HPVV uptake is largely hindered by vaccine attitudes driven by either lack of awareness (Cartmell et al., Citation2018) information and literacy (Alhusayn et al., Citation2022; Fernandes et al., Citation2018) or its adequacy (Lubeya et al., Citation2022). The study adds to the literature by highlighting the context-specific barriers and facilitators to the uptake of HPVV at three different levels across SK in an attempt to provide views from multiple prescriptive.

The study advances our understanding of the link between the role of bio, psycho-social, environmental, and political determinants and HPVV uptake. Literature resonates with our findings concerning HPV-related knowledge, attitude and belief (Rubens-Augustson et al., Citation2019; Wilson et al., Citation2021). Our study findings, however, emphasize that vaccine-related logistics could be equally important, if not more. The study findings suggest that emphasizing COVID-19-related services and suspending all other public health and health systems contributed to challenges in HPVV efforts. This study supports the literature articulating the need for robust emergency preparedness plans and policies that can allow for engagement with emergencies while maintaining other routine public health and healthcare functions to continue (Haldane et al., Citation2021; Margherita et al., Citation2021)

Most findings from the initial interviews data set were confirmed with the findings from the follow-up interviews, document analysis and literature. Stakeholders agreed there had been significant erosion of trust in public health and the health system (Hurt, Citation2022) at large due to some short-term misfit policies during the COVID-19 pandemic, and it will take some time to regain the trust (Confusing COVID-19 advice is undermining public trust; here’s how to restore it, Citation2020; Henderson et al., Citation2020). Stakeholders resonated on the idea of periodic education (Fernandes et al., Citation2018; Tung et al., Citation2016) and thought of reoffering HPVV to high school youth and possibly universities. Literature, however, supports the implementation of universal HPVV programmes (Salvadori, Citation2018).

Stakeholders strongly agreed that unambiguous language should be used in introducing HPVV (Dempsey & O’Leary, Citation2018). Vaccine communication (Michel & Goldberg, Citation2021; Rubens-Augustson et al., Citation2019) either verbal or written, via immunization packages should be clear. The vaccine information sheet and consent form should be made (a) simple, less text heavy with a low reading scale, (b) available in different languages, (c)highlight cancer prevention focus, (d) address age appropriateness and related concerns and (e) a user-friendly source that could facilitate and guide parents’ decision-making around HPVV.

Some points of disagreement were found among stakeholders when school spacing for vaccine clinic setup (Enskär et al., Citation2023) was discussed, as this factor varied based on the area the participant represented. Nuances were also observed in the follow-up interviews as stakeholders highlighted the importance of school vaccine education in the context of the health promotion model (García-Toledano et al., Citation2022). They believed that a deliberate effort to connect with the channels of communication youth use (Arede et al., Citation2018) is critical to HPVV effective uptake.

Findings highlighted that while there are guidelines for HPVV uptake by all population types (i.e., special populations with certain diseases or conditions and populations whose immunization record is not certain), there is no working policy or plans for HPVV catchup for migrants who fall outside the routine HPVV programme for equitable HPVV coverage (Rubens-Augustson et al., Citation2019). While our study supports the literature that an age limit to seeking HPVV through the publicly funded programme is certainly a barrier (Giede et al., Citation2010) to its uptake by all population subgroups, we did not find any cultural-related factors (Rubens-Augustson et al., Citation2019) to be a barrier to HPVV uptake.

A major limitation of our study is that we could not assess current area-based coverage rates of HPV immunization of grade sixers (age 9). Therefore, we could not study disparities in the uptake of HPVV all across SK or study regions with lower coverage rates for interviews to explore barriers and facilitators in the uptake of HPVV. While specific findings may not be generalizable beyond the study context, the thematic areas of importance to HPVV may resonate elsewhere, and they can guide thinking about creating robust vaccination programmes in other jurisdictions.

Conclusion

The study findings suggest that successful vaccination strategies must rely on combination approaches that address the needs of different populations and subgroups. HPV-related literacy and vaccine-logistics are equally important and should be reconsidered especially in the context of hybrid digital and analogue world. We recommend a person-centred approach to enhance HPVV uptake using the determinants of HPVV uptake our study highlighted. For example: educating parents on dimensions of individual needs, including giving the right information, handling misconceptions/myths, and addressing specific questions, concerns, or fears. Systems-level thinking approach that centres the patient and family is needed in which we need to look at all levels of the systems to understand and improve uptake rates.

Also, this study warrants sustainable preparation and practice of emergency preparedness plans and policies with continuous audit and feedback loops to avoid neglecting health promotion goals in the times like the COVID-19 crisis. Future research may fruitfully study and update factors of HPVV uptake across regions during emergencies and normal times.

Consent for publication

I consent to publish data and images enclosed with this submission.

Authors contribution

Dr. Amal Khan conceptualized and designed the conduct of the review, conducted data collection, sorting, organization and interpreted data and prepared and revised the manuscript; Dr. Cory Neudorf, contributed to the conceptualization of the review, its design, and data interpretation and reviewed the manuscript; Dr. Sylvia Abonyi contributed to the conceptualization of the review, its design, and results interpretation and reviewed and revised the manuscript; Dr. Shahid Ahmed contributed to the study conceptualization, and reviewed and revised the manuscript; Dr. Sandro Galea contributed to the interpretation of the results and reviewed and revised the manuscript and provided valuable insights and feedback overall.

Supplemental material

Interview guide 1_Provider level_clean.docx

Download MS Word (23.4 KB)

Interview Guide 3_Provider+System Level_clean.docx

Download MS Word (21.1 KB)

Interview Guide 2_System level_clean.docx

Download MS Word (23.8 KB)

Acknowledgments

Thilina Bandara, Benjamin Neudorf, Mika Rathwell, and Charles Plante.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Supplementary material

Supplemental data for this article can be accessed online at https://doi.org/10.1080/17482631.2023.2295879.

Additional information

Funding

Funding support received from Canadian Partnership Against Cancer.

Notes on contributors

Amal Khan

Amal Khan is a physician and population health specialist. She is an elected member of the board of directors at Basic Income Canada Network. She completed her medical degree from Combined Military Hospital, Lahore and her Master’s in Community and Population Health Sciences at the University of Saskatchewan, Canada and is now a Ph.D. Candidate at the same institute. She studied population health dynamics as a functional proxy of equity in society, economy, politics and beyond. She is working on a large national (Canada-wide) project under the Urban Public Health Network with a lens of equity, contributing to monitoring Population Health and Local Public Health Action in Urban Canada. Her research journey has shaped her belief and driven her passion, where one cannot keep oneself from the action. Her research interests include Health Equity, Social Determinants of Health, Immigrant and Refugee Health, Preventable Cancers, Mixed methods designs, Qualitative and Quantitative Data Collection & Analysis, and Medicine and Society. Amal is a member of the Canadian Cancer Society Research Institute. She is currently working to co-develop a rapid diagnosis programme for the early detection of upper gastrointestinal cancers with an equity lens at the Saskatchewan Cancer Agency.

Sylvia Abonyi

Sylvia Abonyi I am the Canadian-born daughter of an immigrant and refugee, a wife, and the mother of two. As an educator, health researcher, and citizen in Canada, I teach, learn, work, and live on traditional Indigenous territories that include treaty lands, unceded lands, and Métis homelands. I pay my respects to the First Nation, Métis, and Inuit ancestors. Trained as an anthropologist, I conduct community engaged research with First Nation and Métis communities and peoples, primarily from northern Saskatchewan. Recent studies focus on healthy ageing in place, tuberculosis, sleep health, as well as heart and lung health. Together with Indigenous community partners, I am also part of national and provincial teams revealing experiences of covid-19. In addition to my position in the department, I am research faculty with the Saskatchewan Population Health and Evaluation Research Unit (www.SPHERU.ca), an interdisciplinary group of researchers from the Universities of Saskatchewan and Regina whose collective focus is on advancing health equity through the creation of new knowledge, independent policy analysis, and collaborative research with policymakers and communities.

Cory Neudorf

Cory Neudorf as a public health physician and epidemiologist, he has spent his career devoted to health equity and public health advocacy. For more than 20 years, Neudorf served as chief medical officer for the former Saskatoon Health Region. Recently, he served as the interim senior medical health officer with the Saskatchewan Health Authority. Neudorf is also involved with public health at the national level as the current president of the Urban Public Health Network of Canada, former president of both the Canadian Public Health Association and the Public Health Physicians of Canada, liaison member with the Regions for Health Network (WHO Europe) and advisor for the Public Health Agency of Canada. To him, Public Health provides the chance to influence health and other policy and get more upstream on issues rather than individual patient issues, which appeals to him. He describes himself as a health geek. It’s an apt description of a man who has spent the past 24 years dedicated to promoting and protecting the health of people in communities in Saskatchewan and around the world. He has travelled to northern Saskatchewan, as well as Eastern Europe and Central Asia – nearly 20 countries all together – in the interest of global health.

Sandro Galea

Sandro Galea a physician, epidemiologist, and author, is dean and Robert A. Knox Professor at Boston University School of Public Health. In 2015, he became the youngest public health dean in the country, assuming leadership of the Boston University School of Public Health. One of the most widely-cited scholars in the social sciences, Galea has published more than 950 scientific journal articles, 70 chapters, and 19 books. He has published extensively in the peer-reviewed literature about the social causes of health, mental health, and trauma. His research has been principally funded by the National Institutes of Health, Centers for Disease Control and Prevention, and philanthropic foundations. Galea has received several lifetime achievement awards for his research, including the Rema Lapouse Award from the American Public Health Association and the Robert S. Laufer, PhD, Memorial Award from the International Society for Traumatic Stress Studies. Galea holds a medical degree from the University of Toronto, graduate degrees from Harvard University and Columbia University, and an honorary doctorate from the University of Glasgow. Prior to his appointment at Boston University, Galea served as the Gelman Professor and Chair of the Department of Epidemiology at the Columbia University Mailman School of Public Health.

Shahid Ahmed

Shahid Ahmedgraduated from Dow Medical University of Health Sciences, Karachi, in 1996. He completed his training in Internal Medicine and Medical Oncology at the Long Island Jewish Medical Center, Albert Einstein College of Medicine, New York, in 2003. He completed his Doctor of Philosophy in Community and Population Health Science from the University of Saskatchewan in 2016. He is a fellow of the American College of Physicians and the Royal College of Physicians and Surgeons of Canada. Shahid joined the Saskatoon Cancer Center in 2003 as a medical oncologist. His area of interest is breast and gastrointestinal oncology. In addition to patient care, he is committed to medical education and research. He is an active member of various local and national committees that are involved in patient care, medical education, and research. He has served as a continuing professional development educator for the Royal College of Physicians and Surgeons of Canada. He holds several research grants and actively engages in collaborative research and clinical trials. Shahid has presented his works at several international meetings, published more than 70 articles in peer-reviewed journals, and author of several book chapters.

References

  • Alhusayn, K. O., Alkhenizan, A., Abdulkarim, A., Sultana, H., Alsulaiman, T., & Alendijani, Y. (2022). Attitude and hesitancy of human papillomavirus vaccine among Saudi parents. Journal of Family Medicine and Primary Care, 11(6), 2909–22. https://doi.org/10.4103/jfmpc.jfmpc_2377_21
  • Arede, M., Bravo-Araya, M., Bouchard, É., Singh Gill, G., Plajer, V., Shehraj, A., & Adam Shuaib, Y. (2018). Combating vaccine hesitancy: Teaching the next generation to navigate through the Post Truth Era. anxiety and depression among health Sciences students in home quarantine during the COVID-19 pandemic in selected provinces of Nepal. Frontiers in Public Health, 6, 381. https://doi.org/10.3389/fpubh.2018.00381
  • Background and key statistics. (2021, March 29). Canadian Partnership Against Cancer. Retrived April 2, 2023. https://www.partnershipagainstcancer.ca/topics/hpv-immunization-policies/background-key-statistics/
  • Beshears, J., Choi, J. J., Laibson, D. I., Madrian, B. C., & Reynolds, G. I. (2016). Vaccination rates are associated with functional proximity but not base proximity of vaccination clinics. Medical Care, 54(6), 578–583. https://doi.org/10.1097/MLR.0000000000000523
  • Bhugra, P., Grandhi, G. R., Mszar, R., Satish, P., Singh, R., Blaha, M., Blankstein, R., Virani, S. S., Cainzos-Achirica, M., & Nasir, K. (2021). Determinants of influenza vaccine uptake in patients with cardiovascular Disease and strategies for improvement. Journal of the American Heart Association, 10(15), e019671. https://doi.org/10.1161/JAHA.120.019671
  • Borrell-Carrió, F., Suchman, A. L., & Epstein, R. M. (2004). The biopsychosocial model 25 years later: Principles, practice, and scientific inquiry. Annals of Family Medicine, 2(6), 576–582. https://doi.org/10.1370/afm.245
  • Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
  • Canadian Cancer Society’s Advisory Committee on Cancer Statistics. (2016). Special Topic: HPV-Associated Cancers. (Members of the Canadian Cancer Statistics Advisory Committee, ed.).
  • Canadian Cancer Society, Statistics Canada, the Public Health Agency of Canada. (2020). 2020-Canadian-Cancer-Statistics-Special-Report-EN.pdf. https://www.cancer.ca/en/cancer-information/cancer-101/canadian-cancer-statistics/?region=on
  • Canadian Partnership Against Cancer. (2021) HPV Immunization for the Prevention of Cervical Cancer.
  • Cancers associated with human Papillomavirus (HPV). (2022, October 4). Retrieved March 27, 2023. https://www.cdc.gov/cancer/hpv/basic_info/cancers.htm
  • Cartmell, K. B., Young-Pierce, J., McGue, S., Alberg, A. J., Luque, J. S., Zubizarreta, M., & Brandt, H. M. (2018). Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action. Papillomavirus Research, 5, 21–31. https://doi.org/10.1016/j.pvr.2017.11.003
  • Cervical cancer. Retrieved March 27, 2023. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
  • Confusing COVID-19 advice is undermining public trust; here’s how to restore it. (2020, October 9). CBC News Retrived May 29, 2023. https://www.cbc.ca/radio/whitecoat/confusing-covid-19-advice-is-undermining-public-trust-here-s-how-to-restore-it-1.5755220
  • Crawshaw, A. F., Farah, Y., Deal, A., Rustage, K., Hayward, S. E., Carter, J., Knights, F., Goldsmith, L. P., Campos-Matos, L., Wurie, F., Majeed, A., Bedford, H., Forster, A. S., & Hargreaves, S. (2022). Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. The Lancet Infectious Diseases, 22(9), e254–e266. https://doi.org/10.1016/s1473-3099(22)00066-4
  • de Martel, C., Plummer, M., Vignat, J., & Franceschi, S. (2017). Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer Journal international du cancer, 141(4), 664–670. https://doi.org/10.1002/ijc.30716
  • Dempsey, A. F., & O’Leary, S. T. (2018). Human Papillomavirus Vaccination: Narrative Review of Studies on How Providers’ Vaccine Communication Affects Attitudes and Uptake. Academic Pediatrics, 18(2S), S23–S27. https://doi.org/10.1016/j.acap.2017.09.001
  • Eliminating HPV-related cancers. Ontario Pharmacists Association |. (2022, June 25). Retrieved May 29, 2023. https://opatoday.com/eliminating-hpv-related-cancers/
  • Enskär, I., Enskär, K., Nevéus, T., Hess Engström, A., & Grandahl, M. (2023). Barriers in the School-Based Pan-Gender HPV Vaccination Program in Sweden: Healthcare Providers’ Perspective. Vaccines (Basel), 11(2), 310. https://doi.org/10.3390/vaccines11020310
  • Fernandes, R., Potter, B. K., & Little, J. (2018). Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada. BMC women’s health, 18(1), 134. https://doi.org/10.1186/s12905-018-0622-0
  • Fisk, R. J. (2021). Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Global Health Journal, 5(1), 51–55. https://doi.org/10.1016/j.glohj.2021.02.005
  • García-Toledano, E., López-Parra, E., Cebrián-Martínez, A., & Palomares-Ruiz, A. (2022). The Need for Health Education and Vaccination—Importance of Teacher Training and Family Involvement. Healthcare (Basel), 10(1), 110. https://doi.org/10.3390/healthcare10010110
  • Giede, C., McFadden, L. L., Komonoski, P., Agrawal, A., Stauffer, A., & Pierson, R. (2010). The acceptability of HPV vaccination among women attending the University of Saskatchewan Student Health Services. Journal of obstetrics and gynaecology Canada, 32(7), 679–686. https://doi.org/10.1016/S1701-2163(16)34572-8
  • Government of Canada, Canada S. Focus on Geography Series, 2021 Census - Saskatchewan. (2022 July 13). Retrived April 20, 2023. https://www12.statcan.gc.ca/census-recensement/2021/as-sa/fogs-spg/Page.cfm?Lang=E&Dguid=2021A000247&topic=1
  • Government of Canada, Canada, S. Profile table, Census profile, 2021 Census of Population - Prince Albert, City (CY) [Census subdivision], Saskatchewan. (2022, February 9). Retrived May 29, 2023. https://www12.statcan.gc.ca/census-recensement/2021/dp-pd/prof/details/page.cfm?Lang=E&SearchText=Prince%20Albert&DGUIDlist=2021A00054715066&GENDERlist=1&STATISTIClist=1&HEADERlist=0
  • Government of Canada, Canada, S. Profile table, Census Profile, 2021 Census of Population - Regina, City (CY) [Census subdivision], Saskatchewan;Saskatoon, City (CY) [Census subdivision], Saskatchewan. (2022, February 9). Retrived May 29, 2023. https://www12.statcan.gc.ca/census-recensement/2021/dp-pd/prof/details/page.cfm?Lang=E&SearchText=SASKATOON&DGUIDlist=2021A00054706027,2021A00054711066&GENDERlist=1,2,3&STATISTIClist=1&HEADERlist=0
  • Green, J., & Thorogood, N. (2018). Qualitative Methods for Health Research. SAGE Publications.
  • Haldane, V., De Foo, C., Abdalla, S. M., Jung, A. S., Tan, M., Wu, S., Chua, A., Verma, M., Shrestha, P., Singh, S., Perez, T., Tan, S. M., Bartos, M., Mabuchi, S., Bonk, M., McNab, C., Werner, G. K., Panjabi, R., Nordström, A., & Legido-Quigley, H. (2021). Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nature medicine, 27(6), 964–980. https://doi.org/10.1038/s41591-021-01381-y
  • Henderson, J., Ward, P. R., Tonkin, E., Meyer, S. B., Pillen, H., McCullum, D., Toson, B., Webb, T., Coveney, J., & Wilson, A. (2020). Developing and Maintaining Public Trust During and Post-COVID-19: Can We Apply a Model Developed for Responding to Food Scares? Anxiety and Depression Among Health Sciences Students in Home Quarantine During the COVID-19 Pandemic in Selected Provinces of Nepal. Frontiers in Public Health, 8, 369. https://doi.org/10.3389/fpubh.2020.00369
  • HPV immunization for the prevention of cervical cancer. Canadian Partnership Against Cancer. (2021, March 29). Retrived May 29, 2023. https://www.partnershipagainstcancer.ca/topics/hpv-immunization-policies/
  • HPV vaccine access in Canada, 2022. (2022, November 15). Canadian Partnership Against Cancer. Retrived March 23, 2023. https://www.partnershipagainstcancer.ca/topics/hpv-vaccine-access-2022/
  • Human papilloma virus (HPV) vaccine offered to boys beginning this fall. Government of Saskatchewan. Retrived February 28, 2023. https://www.saskatchewan.ca/government/news-and-media/2017/september/08/hpv-vaccine
  • Hurt, M. C. (2022). Distrust of Public Health’s Response to the COVID-19 Pandemic. The American journal of nursing, 122(6), 53–56. https://doi.org/10.1097/01.NAJ.0000833936.15485.9e
  • Immunization services. Government of Saskatchewan. Retrived April 16, 2023. https://www.saskatchewan.ca/residents/health/accessing-health-care-services/immunization-services
  • Khan, A., Abonyi, S., & Neudorf, C. (2023, February). Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review. Where to from Here? Human Vaccines and Immunotherapeutics, 19(1), 2176640. https://doi.org/10.1080/21645515.2023.2176640
  • Levesque, J. F., Harris, M. F., & Russell, G. (2013). Patient-centred access to health care: conceptualising access at the interface of health systems and populations. International journal for equity in health, 12(1), 18. https://doi.org/10.1186/1475-9276-12-18
  • Lubeya, M. K., Zekire Nyirenda, J. C., Chanda Kabwe, J., & Mukosha, M. M. (2022). Knowledge, Attitudes and Practices Towards Human Papillomavirus Vaccination Among Medical Doctors at a Tertiary Hospital: A Cross Sectional Study. Cancer control : journal of the Moffitt Cancer Center, 29, 10732748221132646. https://doi.org/10.1177/10732748221132646
  • Margherita, A., Elia, G., & Klein, M. (2021). Managing the COVID-19 emergency: A coordination framework to enhance response practices and actions. Technological Forecasting and Social Change, 166, 120656. https://doi.org/10.1016/j.techfore.2021.120656
  • Michel, J. P., & Goldberg, G. J. (2021). Education, Healthy Ageing and Vaccine Literacy. The journal of nutrition, health & aging, 25(5), 698–701. https://doi.org/10.1007/s12603-021-1627-1
  • Morse, J. M. (2010). Simultaneous and Sequential Qualitative Mixed Method Designs. Qualitative inquiry : QI, 16(6), 483–491. https://doi.org/10.1177/1077800410364741
  • Population health branch, Saskatchewan ministry of health. (2019). Vaccine Preventable Disease Monitoring.
  • Rezaei Aghdam, A., Watson, J., Cliff, C., & Miah, S. J. (2020). Improving the Theoretical Understanding Toward Patient-Driven Health Care Innovation Through Online Value Cocreation: Systematic Review. Journal of medical Internet research, 22(4), e16324. https://doi.org/10.2196/16324
  • Rubens-Augustson, T., Wilson, L. A., Murphy, M. S., Jardine, C., Pottie, K., Hui, C., Stafström, M., & Wilson, K. (2019). Healthcare provider perspectives on the uptake of the human papillomavirus vaccine among newcomers to Canada: a qualitative study. Human vaccines & immunotherapeutics, 15(7–8), 1697–1707. https://doi.org/10.1080/21645515.2018.1539604
  • Salvadori, M. I. (2018). Human papillomavirus vaccine for children and adolescents. Paediatrics & Child Health, 23(4), 262–265. https://doi.org/10.1093/pch/pxx179
  • Saskatchewan. Retrived April 20, 2023. https://datacommons.org/place/wikidataId/Q1989?utm_medium=explore&mprop=count&popt=Person&hl=en
  • Saunders, B., Sim, J., Kingstone, T., Baker, S., Waterfield, J., Bartlam, B., Burroughs, H., & Jinks, C. (2018). Saturation in qualitative research: exploring its conceptualization and operationalization. Quality & Quantity, 52(4), 1893–1907. https://doi.org/10.1007/s11135-017-0574-8
  • Smith, A., Baines, N., Memon, S., Fitzgerald, N., Chadder, J., Politis, C., Nicholson, E., Earle, C., & Bryant, H. (2019). Moving toward the elimination of cervical cancer: modelling the health and economic benefits of increasing uptake of human papillomavirus vaccines. Current oncology, 26(2), 80–84. https://doi.org/10.3747/co.26.4795
  • Structural Profile of Public Health in Canada: Indigenous health. National Collaborating Centre for Healthy Public Policy. (2019, December 9). Retrived May 29, 2023. https://ccnpps-ncchpp.ca/structural-profile-of-public-health-in-canada-indigenous-health/
  • Thorne, S. (2016). Interpretive Description: Qualitative Research for Applied Practice. Routledge.
  • Tracy, S. J. (2010). Qualitative Quality: Eight “Big-Tent” Criteria for Excellent Qualitative Research. Qualitative inquiry : QI, 16(10), 837–851. https://doi.org/10.1177/1077800410383121
  • Tung, I. L. Y., Machalek, D. A., Attitudes, G. S., & Consolaro, M. E. L. (2016). Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia. PLoS One, 11(8), e0161846. https://doi.org/10.1371/journal.pone.0161846
  • Wikipedia contributors. List of cities in Saskatchewan. Wikipedia, The Free Encyclopedia. (2023, February 13). https://en.wikipedia.org/w/index.php?title=List_of_cities_in_Saskatchewan&oldid=1139144800
  • Wilson, L. A., Quan, A. M. L., Bota, A. B., Mithani, S. S., Paradis, M., Jardine, C., Hui, C., Pottie, K., Crowcroft, N., & Wilson, K. (2021). Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination. BMC family practice, 22(1), 17. https://doi.org/10.1186/s12875-020-01360-1
  • World Health Organization. (2001) . International classification of functioning, disability and health (ICF).